ABIVAX's ABX464 Reduces HIV Reservoir in Blood in Second Phase 2a Clinical Trial - Markets Insider
Submitted by Paris Editor on Thu, 09/28/2017 - 20:38
English
© International Association of Providers of AIDS Care. All Rights Reserved. This webportal was developed through a partnership between IAPAC and Dure Technologies, and produced with financial support from multiple donors, none of which had any editorial input or control over its content.
